Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway

Diabetic cardiomyopathy (DCM) is a complication of diabetes that can cause damage to myocardial structure and function. Metformin (Met) is a widely used type 2 diabetes treatment drug that exerts cardioprotective effects through multiple pathways. Prokineticin 2 (PK2) is a small-molecule secreted pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhen, Wang, Min, Zhang, Yuchen, Cai, Fei, Jiang, Botao, Zha, Wenliang, Yu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252307/
https://www.ncbi.nlm.nih.gov/pubmed/32508669
http://dx.doi.org/10.3389/fphys.2020.00425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252307/
https://www.ncbi.nlm.nih.gov/pubmed/32508669
http://dx.doi.org/10.3389/fphys.2020.00425

Ejemplares similares